萧寅康
合伙人
上海
Anthony Siu是驻上海的合伙人。于2016年加入BDA，在加入BDA之前，他在Robert W. Baird任职8年，带领大中华投行团队负责大中华区和美国及欧洲的跨境并购交易。在此之前，他在渣打银行企业顾问部门担任总监，负责政府和私人并购交易。早前，他还曾在大华证券和施罗德工作，完成了多项并购和权益资本市场交易。他曾为多家亚洲企业担任顾问，有China Life, CLP, Hopewell, Kerry, New World, Ping An, Sinochem and Wheelock，也为财务投资者提供过顾问服务，有CDH, CITIC Capital, EQT and Hony。Anthony获得了西北大学Kellogg学院和香港科学技术大学的行政工商管理硕士，并持有美国波莫纳大学的学士学位。他在加利福尼亚获得了CPA证书并曾就职于KPMG的审计部门。他能讲流利的英语，普通话和广东话。
Recent transactions
sold
to
2024
制造业
a portfolio company of
has been acquired by
2024
企业服务
series A capital raise from
Meridian Capital China
2022
消费品
出售给Novo Holdings
2022
医疗
has been acquired by
2021
医疗
a portfolio company of
divested majority stake to
2021
制造业
拟出售给迈瑞医疗
2021
医疗
divested majority stake to
DCP Capital
2021
医疗
divested significant stake in
Kehua Bio-Engineering to Gree Real Estate
2020
医疗
Divested controlling stake to Grass Green Group
2020
消费品
divested majority stake to
2019
医疗
a portfolio company of
has been acquired by
2018
消费品
divested Chinese RTW business to a Hong Kong-based investor
2018
消费品
a portfolio company of
has been acquired by
2018
制造业